Riskpilot← Back to searchSign inGet full accessSpecsavers Järvenpää Oy
OYActiveY-tunnus 3092851-2Äyritie 18Retail sale of medical and orthopaedic goods · NACE 4774Est. 2019— employees
Revenue 2025
EUR 590K
0% vs 2024
EBITDA margin
1.7%
-66% vs 2024
Equity ratio
9.7%
Financial strength
Net profit 2025
EUR -6K
-132% vs 2024
| Revenue | EUR 590K | +0% |
| EBITDA | EUR 10K | -66% |
| Net profit | EUR -6K | -132% |
| Total assets | EUR 495K | +209% |
| Equity | EUR 48K | -11% |
| Employees | — | — |
Legal name
Specsavers Järvenpää Oy
Y-tunnus number
3092851-2
Legal form
Osakeyhtiö
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
11. lokakuuta 2019
Share capital
EUR 3 025
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-02-28
Financial year
January – December
Company purpose
Yhtiön toimialana on optisen alan tuotteiden ja palveluiden tarjoaminen.
Address
Äyritie 18
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 512 | 501 | 588 | 590 |
| Staff expenses | −156 | −157 | −179 | −186 |
| EBITDA | 64 | 25 | 29 | 10 |
| Depreciation & amort. | −8 | −9 | −8 | −14 |
| EBIT | 56 | 16 | 21 | −4 |
| Net financials | −1 | −0 | −1 | −2 |
| Profit before tax | 56 | 15 | 19 | −6 |
| Tax | 11 | 3 | −0 | −0 |
| Net profit | 44 | 12 | 19 | −6 |
| Item | 2021 | 2022 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 159 | 120 | 160 | 495 |
| Equity | 98 | 77 | 54 | 48 |
| Long-term debt | — | — | 0 | 39 |
| Short-term debt | 61 | 43 | 106 | 408 |
| Total debt | 61 | 43 | 106 | 447 |
EBITDA margin
1.7%
This company
15.8%
Market median
-89% vs market
20212025
Equity ratio
9.7%
This company
38.2%
Market median
-75% vs market
20212025
Return on equity
-12.8%
This company
18.4%
Market median
-170% vs market
20212025
Net profit margin
-1.0%
This company
8.1%
Market median
-112% vs market
20212025
Asset turnover
1.19×
This company
1.12×
Market median
+6% vs market
20212025
Debt / equity
9.36×
This company
0.62×
Market median
-1410% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2024-03-01 – 2025-02-28
- Annual report 2024Filed via PRH / YTJ · Period 2023-03-01 – 2024-02-29
- Annual report 2022Filed via PRH / YTJ · Period 2021-03-01 – 2022-02-28
- Annual report 2021Filed via PRH / YTJ · Period 2019-09-01 – 2021-02-28
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
AT | Audit | 2019 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2025 | |
| Chairperson | 2024 | |
| Board of Directors | 2021 | |
| Former (5) | ||
| Board of Directors | 2020 – 2025 | |
| Board of Directors | 2020 – 2022 | |
| Board of Directors | 2019 – 2021 | |
| Board of Directors | 2019 – 2020 | |
| Chairperson | 2019 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Specsavers Järvenpää Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| André Trygve Kumlander | Audit | 0 companies |
| Riku-Matti Taneli Kuusisto | Board of Directors | 0 companies |
| Tapio Antero Koivu | Board of Directors | 0 companies |
| Erkki Antero Tala | Board of Directors | 0 companies |
| Henning Jørgen Eriksen Færden | Board of Directors | 0 companies |
| Richard Neil Owens | Chairperson | 0 companies |
| Johanna Lakkala | Board of Directors | 0 companies |
| Liisa Lotta Holmaheikki | Board of Directors | 0 companies |
| Nigel David Parker | Chairperson | 0 companies |